Hereditary Amino Acid Metabolism Disorders and Urea Cycle Disorders: to Practicing Physician

Hereditary amino acid metabolism disorders (aminoacidopathies) are clinically and genetically heterogeneous group of hereditary metabolic diseases caused by enzymes deficiency involved in amino acid metabolism, that finally leads to progressive damage of central nervous system, liver, kidneys, and other organs and systems. Hereditary urea cycle disorders occur because of enzyme deficiency leading to impaired urea synthesis and hyperammoniemia in patients. The age of disease onset and clinical manifestations severity range from milder, intermittent forms to severe, manifesting in the first hours of life. Expanded neonatal screening (implemented in Russian Federation at 01.01.2023) allows to diagnose diseases from these groups in the first days of life, to prescribe timely pathogenetic therapy. Altogether it helps to prevent the development of disease severe complications. Raising awareness about hereditary aminoacidopathies and urea cycle disorders among pediatricians, neonatologists, neurologists, gastroenterologists, ophthalmologists is a topical issue of modern pediatrics.

1. Dalili S, Talea A, Aghajany-Nasab M, et al. Clinical Features and Laboratory Diagnosis of Aminoacidopathies: A Narrative Review. Arch Neurosci. 2023;10(3):e136721. doi: https://doi.org/10.5812/ans-136721

2. Aliu E, Kanungo S, Arnold GL. Amino acid disorders. Ann Transl Med. 2018;6(24):471–476. doi: https://doi.org/10.21037/atm.2018.12.12

3. Order of the Ministry of Health of the Russian Federation No 274н dated April 21, 2022 “Ob utverzhdenii poryadka okazaniya meditsinskoi pomoshchi patsientam s vrozhdennymi i/ili nasledstvennymi zabolevaniyami”. (In Russ). Доступно по: https://base.garant.ru/404987183. Ссылка активна на 03.12.2023.

4. Lee N, Kim D. Toxic Metabolites and Inborn Errors of Amino Acid Metabolism: What One Informs about the Other. Metabolites. 2022;12(6):527–532. doi: https://doi.org/10.3390/metabo12060527

5. Klassicheskaya fenilketonuriya i drugie vidy giperfenilalaninemii: Clinical guidelines. Association of Medical Genetics; Initiative of pediatrics and neonatology specialists in the development of clinical practices; Union of Pediatricians of Russia. 2020. 112 p. (In Russ). Доступно по: https://www.pediatr-russia.ru/information/klin-rek/proekty-klinicheskikh-rekomendatsiy/%D0%9A%D0%A0%20%D0%A4%D0%9A%D0%A3_%D0%93%D0%A4%D0%90%20%D0%B2%20%D0%9C%D0%97%20%D0%A0%D0%A4.pdf. Ссылка активна на: 03.12.2023.

6. Zielonka M, Kölker S, Gleich F, et al. Early Prediction of Phenotypic Severity in Citrullinemia Type 1. Ann Clin Transl Neurol. 2019;6(9):1858–1871. doi: https://doi.org/10.1002/acn3.50886

7. Amino acid: Part 8. In: The Online Metabolic and Molecular Bases of Inherited Disease. Valle DL, Antonarakis S, Ballabio A, et al., eds. McGraw Hill; 2019. Available online: https://ommbid.mhmedical.com/content.aspx?bookid=2709&sectionid=225069235. Accessed on December 03, 2023.

8. Carter MT, Srour M, Au PB, et al. Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG). J Med Genet. 2023;60(6):523–532. doi: https://doi.org/10.1136/jmg-2022-108962

9. Mikhailova SV, Zakharova EYu, Petrukhin AS. Neirometabolicheskie zabolevaniya u detei i podrostkov: diagnostika i podkhody k lecheniyu. 2nd ed. Moscow: Litterra; 2019. 368 p. (In Russ).

10. Hajji H, Imbard A, Spraul A, et al. Initial presentation, management and follow-up data of 33 treated patients with hereditary tyrosinemia type 1 in the absence of newborn screening. Mol Genet Metab Rep. 2022;8(33):1009–1033. doi: https://doi.org/10.1016/j.ymgmr.2022.100933

11. Nasledstvennaya tirozinemiya I tipa: Clinical guidelines. Union of Pediatricians of Russia; Association of Medical Genetics. 2021. 62 p. (In Russ). Доступно по: https://pediatr-russia.ru/information/klin-rek/proekty-klinicheskikh-rekomendatsiy/КР%20тирозинемия%20_финал.pdf. Ссылка активна на 03.12.2023.

12. Čulic V, Betz RC, Refke M, et al. Tyrosinemia type II (Richner– Hanhart syndrome): A new mutation in the TAT gene. Eur J Med Genet. 2011;54(3):205–208. doi: https://doi.org/10.1016/j.ejmg.2010.11.013

13. Najafi R, Mostofizadeh N, Hashemipour MA. Case of Tyrosinemia Type III with Status Epilepticus and Mental Retardation. Adv Biomed Res. 2018;7:7. doi: https://doi.org/10.4103/2277-9175.223740

14. Roopnarinesingh RC, Donlon NE, Reynolds JV. Alkaptonuria: clinical manifestations and an updated approach to treatment of a rare disease. BMJ Case Rep. 2021;14(12):e244240. doi: https://doi.org/10.1136/bcr-2021-244240

15. Bolezn' “klenovogo siropa” u detei: Clinical guidelines. Union of Pediatricians of Russia. Ministry of Health of Russia; 2018. 35 p.(In Russ). Доступно по: https://www.pediatr-russia.ru/information/klin-rek/deystvuyushchie-klinicheskie-rekomendatsii/%D0%91%D0%BE%D0%BB%D0%B5%D0%B7%D0%BD%D1%8C%20%D0%BA%D0%BB%D0%B5%D0%BD%D0%BE%D0%B2%D0%BE%D0%B3%D0%BE%20%D1%81%D0%B8%D1%80%D0%BE%D0%BF%D0%B0%20%D0%B4%D0%B5%D1%82%D0%B8%20%D0%A1%D0%9F%D0%A0.v2_2018.pdf. Ссылка активна на 03.12.2023.

16. Pode-Shakked N. Clues and challenges in the diagnosis of intermittent maple syrup urine disease. Eur J Med Genet. 2020;63(6): 103–109. doi: https://doi.org/10.1016/j.ejmg.2020.103901

17. Narushenie obmena serosoderzhashchikh aminokislot (gomotsistinuriya): Clinical guidelines. Union of Pediatricians of Russia; Association of Medical Genetics. 2021. — 44 p. (In Russ). Доступно по: https://www.pediatr-russia.ru/information/klin-rek/proekty-klinicheskikh-rekomendatsiy/%D0%93%D0%BE%D0%BC%D0%BE%D1%86%D0%B8%D1%81%D1%82%D0%B8%D0%BD%D1%83%D1%80%D0%B8%D1%8F_1.06.2021.pdf. Ссылка активна на 03.12.2023.

18. Bittmann S, Villalon G, Moschuring-Alieva E, et al. Current and Novel Therapeutical Approaches of Classical Homocystinuria in Childhood With Special Focus on Enzyme Replacement Therapy, Liver-Directed Therapy and Gene Therapy. J Clin Med Res. 2023;15(2):76–83. doi: https://doi.org/10.14740/jocmr4843

19. Bayrak H, Yıldız Y, Olgaç A, et al. Genotypic and phenotypic features in Turkish patients with classic nonketotic hyperglycinemia. Metab Brain Dis. 2021;36(6):1213–1222. doi: https://doi.org/10.1007/s11011-021-00718-3

20. Huynh MT, Landais E, Agathe JS, et al. Novel homozygous GLDC variant causing late-onset glycine encephalopathy: A case report and updated review of the literature. Mol Genet Metab Rep. 2023;6(34):1009–1059. doi: https://doi.org/10.1016/j.ymgmr

21. Narusheniya tsikla obrazovaniya mocheviny: Methodological guidelines. Union of Pediatricians of Russia; Association of Medical Genetics; Russian Society of Neonatologists; National Association of Children’s Rehabilitologists. 2022. 72 p. (In Russ). Доступно по: https://www.pediatr-russia.ru/news/%D0%9C%D0%A0_%D0%BD%D0%B0%D1%80%D1%83%D1%88%D0%B5%D0%BD%D0%B8%D0%B5%20%D1%86%D0%B8%D0%BA%D0%BB%D0%B0%20%D0%BC%D0%BE%D1%87%D0%B5%D0%B2%D0%B8%D0%BD%D1%8B_%D1%80%D0%B5%D0%B4_04.02.22.pdf. Ссылка активна на 03.12.2023.

22. Matsumoto S, Häberle J, Kido J, et al. Urea cycle disorders-update. J Hum Genet. 2019;64(9):833–847. doi: https://doi.org/10.1038/s10038-019-0614-4

23. Bernstein L, Rohr F, Van Calcar S. Nutrition Management of Inherited Metabolic Diseases. 2nd ed. Cham, Switzerland: Springer; 2015. 277 p. doi: https://doi.org/10.1007/978-3-319-14621-8

24. Order of the Government of the Russian Federation of December 11, 2019 No. 2984-р “Ob utverzhdenii perechnya spetsializirovannykh produktov lechebnogo pitaniya dlya detei-invalidov na 2020 g.”. (In Russ). Доступно по: https://www.garant.ru/products/ipo/prime/doc/73120657. Ссылка активна на 03.12.2023.

25. Cunningham A, Rohr F, Splett P, et al. Nutrition management of PKU with pegvaliase therapy: update of the web-based PKU nutrition management guideline recommendations. Orphanet J Rare Dis. 2023;18(1):155–161. doi: https://doi.org/10.1186/s13023-023-02751-0